CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 81 enrolled
Drug / intervention
Sevoflurane +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07289945
NCT07289945Phase 3Completed

A COMPARATIVE STUDY OF DESFLURANE VERSUS SEVOFLURANE IN ELDERLY PATIENTS: EFFECT ON EARLY RECOVERY

Hopital Charles Nicolle·interventional·Posted Dec 17, 2025·Updated Dec 17, 2025

In Brief

A Phase 3 clinical trial evaluating Sevoflurane and Desflurane for Early Recovery in Elderly Patients and Cognitive Function. Completed, enrolled 81 participants across 1 site.

Detailed Summary

The goal of this clinical study is to compare the effects of desflurane versus sevoflurane on early postoperative recovery and cognitive function in elderly patients (aged 60 years and older, ASA I-III) undergoing elective non-cardiac surgery under general anesthesia. The main questions this study aims to answer are: Which anesthetic agent allows faster emergence from anesthesia (eye opening, response to commands, extubation)? Does desflurane lead to earlier cognitive recovery as measured by the Short Orientation Memory Concentration Test (SOMCT)? Does the choice of volatile anesthetic influence the time required to achieve a modified Aldrete score (MAS) ≥ 9 and PACU discharge readiness? Researchers compared the desflurane group to the sevoflurane group to determine whether desflurane provides a superior recovery profile and minimizes delayed emergence in elderly surgical patients. Participants will: Be randomly assigned to receive either desflurane or sevoflurane for maintenance of general anesthesia. Undergo standardized induction with fentanyl, propofol, and cisatracurium, along with uniform ventilatory and monitoring protocols. Have emergence parameters recorded immediately after discontinuation of the inhaled agent (eye opening, command following, extubation). Be evaluated in the post-anesthesia care unit using the modified Aldrete Score (MAS) and SOMCT, with predefined thresholds for recovery (MAS ≥ 9, SOMCT ≥ 20). This study aims to determine whether desflurane-due to its lower blood/gas partition coefficient-offers measurable clinical benefits in terms of rapid awakening, cognitive recovery, and overall early postoperative recovery in the geriatric population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTunisia
Collaborators--

Timeline

Phase 3CompletedFinished
20252026
First PostedDec 17, 2025
Enrollment StartSep 15, 2024
Primary CompletionApr 15, 2025
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7 months ago

Interventions

Sevofluranedrug

Sevoflurane used for anesthesia maintenance with a MAC of 2-3% and FGF of less than 1 L/min.

Desfluranedrug

Desflurane used for anesthesia maintenance with a MAC of 4-6% and FGF of less than 0.5 L/min.